E-LIB Suche - Ergebnisse für: Fry, David W.

1

Generation and external validation of a tumor‐derived 5‐gen..:

Lenehan, Peter F. ; Boardman, Lisa A. ; Riegert‐Johnson, Douglas...
Cancer. 118 (2012) 21 - p. 5234-5244 , 2012

Link: https://doi.org/10.1002/..

2

Using genetic programming to classify node positive patient..:

, In: Proceedings of the 8th annual conference on Genetic and evolutionary computation,

Almal, Arpit A. ; Mitra, Anirban P. ; Datar, Ram H.... - p. 239-246 , 2006

Link: https://dl.acm.org/doi/1..

3

Tyrosine Kinase Inhibitors. 19. 6-Alkynamides of 4-Anilinoq..:

Klutchko, Sylvester R. ; Zhou, Hairong ; Winters, R. Thomas...
Journal of Medicinal Chemistry. 49 (2006) 4 - p. 1475-1485 , 2006

Link: https://doi.org/10.1021/..

4

The use of genetic programming in the analysis of quantitat..:

Mitra, Anirban P ; Almal, Arpit A ; George, Ben...
BMC Cancer. 6 (2006) 1 - p. , 2006

Link: https://doi.org/10.1186/..

5

Discovery of a Potent and Selective Inhibitor of Cyclin-Dep..:

Toogood, Peter L. ; Harvey, Patricia J. ; Repine, Joseph T....
Journal of Medicinal Chemistry. 48 (2005) 7 - p. 2388-2406 , 2005

Link: https://doi.org/10.1021/..

6

2-Aminoquinazoline inhibitors of cyclin-dependent kinases:

Bathini, Yadagiri ; Singh, Inderjit ; Harvey, Patricia J....
Bioorganic & Medicinal Chemistry Letters. 15 (2005) 17 - p. 3881-3885 , 2005

Link: https://doi.org/10.1016/..

7

Pyrido[2,3-d]pyrimidin-7-ones as Specific Inhibitors of Cyc..:

VanderWel, Scott N. ; Harvey, Patricia J. ; McNamara, Dennis J....
Journal of Medicinal Chemistry. 48 (2005) 7 - p. 2371-2387 , 2005

Link: https://doi.org/10.1021/..

8

Mechanism of action of erbB tyrosine kinase inhibitors:

, In: The EGF Receptor Family,

Fry, David W. - p. 137-145 , 2003

Link: https://doi.org/10.1016/..

9

CONTRIBUTORS:

, In: Anticancer Drug Development,

Aboagye, Eric Ofori ; Aherne, Wynne ; Baguley, Bruce C.... - p. xi-xii , 2002

Link: https://doi.org/10.1016/..

10

GROWTH FACTOR AND SIGNAL TRANSDUCTION TARGETS FOR CANCER TH..:

, In: Anticancer Drug Development,

Leopold, W.R. ; Bridges, Alex ; Decker, Stuart... - p. 31-53 , 2002

Link: https://doi.org/10.1016/..

11

Differential Utilization and Localization of ErbB Receptor ..:

Stoll, Stefan W. ; Kansra, Sanjay ; Peshick, Scott...
Neoplasia. 3 (2001) 4 - p. 339-350 , 2001

Link: https://doi.org/10.1038/..

12

Cell Cycle and Biochemical Effects of PD 0183812:

Fry, David W. ; Bedford, David C. ; Harvey, Patricia H....
Journal of Biological Chemistry. 276 (2001) 20 - p. 16617-16623 , 2001

Link: https://doi.org/10.1074/..

13

Akt, MAPK (Erk1/2), and p38 Act in Concert to Promote Apopt..:

Nelson, James M. ; Fry, David W.
Journal of Biological Chemistry. 276 (2001) 18 - p. 14842-14847 , 2001

Link: https://doi.org/10.1074/..

14

Tyrosine Kinase Inhibitors. 17. Irreversible Inhibitors of ..:

Smaill, Jeff B. ; Rewcastle, Gordon W. ; Bridges, Alexander J....
Journal of Medicinal Chemistry. 43 (2000) 16 - p. 3199-3199 , 2000

Link: https://doi.org/10.1021/..

15

Anticancer efficacy of the irreversible EGFr tyrosine kinas..:

Vincent, Patrick W. ; Bridges, Alex J. ; Dykes, Donald J....
Cancer Chemotherapy and Pharmacology. 45 (2000) 3 - p. 231-238 , 2000

Link: https://doi.org/10.1007/..